Stillbirth and fetal free haemoglobin

Researchers supported by Tommy’s have found that the substance that usually carries oxygen around our blood may have harmful effects on the baby when it escapes from red blood cells.

  • Author's list

    Dr Ian Crocker, Dr Paul Brownbill, Professor Alexander Heazell, Anna Hoaksey

Many babies that are stillborn show signs that there isn’t enough blood flow in the placenta. Sometimes, the blood vessels in the placenta can become too narrow, stopping the baby from getting the nutrients and oxygen it needs. If this goes on for too long, the baby might not be able to grow properly. In the worst cases, the baby’s blood supply can be completely cut off.

Researchers supported by Tommy’s have found that something called cell free fetal haemoglobin might be involved in restricting the blood supply in the placenta. Haemoglobin is a protein that exists in all of our red blood cells. It’s the substance that picks up oxygen so that our blood can transport it around the body. While the baby is growing in the womb, it makes a type of haemoglobin that is slightly different to an adult’s: it binds to oxygen more strongly. This helps the baby to get all the oxygen it needs from the mother’s blood.

If a baby’s haemoglobin is not contained in red blood cells – cell free fetal haemoglobin – it can remove substances in the blood that help the blood vessels to widen. Usually, free haemoglobin is taken out of the blood by an enzyme called HO-1. However, if there is not enough of this enzyme, free haemoglobin is left in the blood, causing the blood vessels to narrow. In turn, this will decrease the flow of blood in the placenta.

To understand better how this can increase the risk of stillbirth, Tommy’s are funding PhD student Anna Hoaksey, to carry on looking at the role of fetal haemoglobin. She will try to find out how levels of HO-1 can get low enough to be harmful, as well as studying potential ways of stopping the blood vessels from becoming too narrow. 

In her recent work, Anna has confirmed that babies with weakened circulation do have the highest levels of cell free fetal haemoglobin. We have identified a drug called hydroxychloroquine (HCQ) that could be used to counteract this problem. Our experiments have shown that HCQ can stop fetal haemoglobin from making the blood vessels too narrow. As HCQ can safely cross the placenta, our next steps are to test this in clinical trials for the treatment of fetal growth restriction and stillbirth.

In the future, this vital work has the potential to find new drugs that will prevent stillbirth. 

Get our research updates

Tommy's funds research across the UK investigating the reasons for pregnancy complications and loss. We can keep you updated on our research news.  If you're interested in being kept updated about our research and news from Tommy's, click here.

This study is fully funded by Tommy's and takes place in a Tommy's centre

Read more on this topic

  • Research into stillbirth

    When a baby dies after 24 weeks of gestation, it is called a stillbirth. Nearly 3000 families a year get the devastating news that their baby is not alive. Our research is helping to change this.
    Research into stillbirth

  • Predicting risk of stillbirth by looking at baby’s heartbeat

    Our researchers are developing a new way to study the heartbeats of unborn babies. This could help doctors spot babies in distress so they can act early to prevent stillbirth.
    Predicting risk of stillbirth by looking at baby’s heartbeat

  • Understanding the causes of stillbirth by studying the placenta

    We still don’t know enough about the changes in the placenta which lead to stillbirth. Our researchers are using cutting-edge techniques to find out more.
    Understanding the causes of stillbirth by studying the placenta

  • The AFFIRM trial for prevention of stillbirth

    Researchers supported by Tommy’s are looking at whether a package of care and resources for pregnant women can help stop stillbirths.
    The AFFIRM trial for prevention of stillbirth

  • MiNESS – is there a link between stillbirth and a woman’s position going to sleep?

    A study led by Professor Alex Heazell at the Tommy’s Stillbirth Research Centre at St Mary’s Hospital, Manchester, investigated the link between stillbirth and a woman’s sleeping pattern.
    MiNESS – is there a link between stillbirth and a woman’s position going to sleep?

  • Diabetes, fetal growth and stillbirth

    Women suffering from diabetes are much more likely to suffer from stillbirths. We want to understand how high blood glucose can affect the growing baby and the placenta, so we can focus on helping women with diabetes to have safe and healthy pregnancies.
    Diabetes, fetal growth and stillbirth

  • Preventing stillbirth: the role of the immune system in rejecting the placenta

    Tommy’s are studying chronic histiocytic intervillositis, which causes the immune system to reject the placenta, leading to stillbirth or miscarriage.
    Preventing stillbirth: the role of the immune system in rejecting the placenta

  • Can low levels of taurine make stillbirth more likely?

    Tommy’s researchers are looking at how the lack of an important nutrient might harm the placenta during pregnancy, putting women at a higher risk of stillbirth.
    Can low levels of taurine make stillbirth more likely?

  • Looking at the effects of ICP and gestational diabetes on the fetal heartbeat

    We don’t know enough how some pregnancy complications can lead to stillbirth. Our researchers are developing new ways to assess the fetal heartbeat to spot babies in distress. This could enable doctors to intervene early and prevent stillbirth.
    Looking at the effects of ICP and gestational diabetes on the fetal heartbeat

  • Understanding how the womb lining matures during pre-eclampsia

    Pre-eclampsia can lead to health problems and sometimes stillbirth, but we don’t know enough about what causes it. Our researchers are studying how the lining of the womb develops during early pregnancy. This could reveal new ways to prevent pre-eclampsia and reduce the risk of stillbirth.
    Understanding how the womb lining matures during pre-eclampsia

  • Homing peptides: targeting drugs to the placenta

    Drugs which could help prevent pregnancy complications can’t reach the placenta effectively. Tommy’s researchers are making use of ‘homing peptides’ to deliver drugs directly to the placenta. This work could help to prevent pregnancy complications and stillbirth.
    Homing peptides: targeting drugs to the placenta

  • ReMIT-2 – a feasibility study for spotting the early signs of complications

    We need better ways to spot the early signs of pregnancy complications. The ReMIT-2 study laid the foundations for a large clinical trial of a blood test which could predict which women need urgent care to prevent stillbirth.
    ReMIT-2 – a feasibility study for spotting the early signs of complications